Skip to main content
Heritage Bio Labs · Research use only
Heritage Bio Labs

Triptorelin GnRHCheck methods and identity

Two triptorelin formulations compared in girls with early puberty

2 numbered sourcesSource years 2025, 2026

Peptides are short chains of amino acids connected by peptide bonds. Some fit onto receptors that control when a gland releases hormones. Triptorelin is a ten-amino-acid synthetic agonist of the receptor for gonadotropin-releasing hormone, or GnRH. Sustained exposure reduces pituitary hormone output. A 2026 study in China compared two sustained formulations in girls with central precocious puberty, a condition in which the brain's usual puberty-signaling pathway starts too early. [1, 2]

The investigators looked back at records for 70 girls treated at one hospital. Families and clinicians chose between the formulations in routine care, and the researchers examined one year of follow-up. The team compared blood levels of luteinizing hormone and follicle-stimulating hormone, two pituitary signals involved in puberty. It also compared skeletal maturation, growth rate, estimated adult height, and ultrasound measurements of the uterus and ovaries. These outcomes show different parts of the response. A hormone test measures a signal in the pathway, while bone age describes how far the skeleton has matured relative to age. [1]

Both groups had lower pituitary hormone levels than at the start. The estimated adult heights rose in both groups, with no clear difference between groups. The team also found no clear group differences in skeletal maturation, growth rate, or the ultrasound measurements. The height estimate is calculated from childhood measurements and a bone-age method. The study observed one year of care, so the participants' eventual adult heights were outside its observation period. [1]

This was a retrospective comparison of the girls who met the study criteria and had the necessary follow-up data. Formulation choice could reflect family preferences, travel, and cost. Random assignment would have better protected the comparison from those differences. The results give a picture of two preparations in one center. In the United States, Triptodur has its own product-specific approval for central precocious puberty in children age two and older. [1, 2]

Sources

Original works cited in this article. Links open the external record in a new tab.

Shop Triptorelin GnRH

Articles from the Heritage Bio Labs research series, with links to the original sources. For research use only; not medical advice. Also available as Markdown or JSON.